The store will not work correctly when cookies are disabled.
N-(3-(5-(benzylsulfanyl)-1,3,4-oxadiazol-2-yl)-5-nitrophenyl)acetamide
ID: ALA4095824
PubChem CID: 137652686
Max Phase: Preclinical
Molecular Formula: C17H14N4O4S
Molecular Weight: 370.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)Nc1cc(-c2nnc(SCc3ccccc3)o2)cc([N+](=O)[O-])c1
Standard InChI: InChI=1S/C17H14N4O4S/c1-11(22)18-14-7-13(8-15(9-14)21(23)24)16-19-20-17(25-16)26-10-12-5-3-2-4-6-12/h2-9H,10H2,1H3,(H,18,22)
Standard InChI Key: ZGVIOUKDVNMGPM-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
16.2465 -3.6311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8634 -4.1671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6360 -3.9009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7917 -3.0987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1749 -2.5627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4023 -2.8290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5795 -2.8155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2504 -3.2822 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.9015 -2.7884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6353 -2.0158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8196 -2.0158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6834 -3.0260 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.2801 -2.4676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0620 -2.7053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2471 -3.5013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0290 -3.7389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6258 -3.1805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4405 -2.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6587 -2.1470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7077 -4.9693 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3245 -5.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1688 -6.3075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0971 -5.2392 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.7816 -2.2916 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0089 -2.5578 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9373 -1.4894 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
2 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
24 25 2 0
24 26 1 0
6 24 1 0
M CHG 2 24 1 26 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 370.39 | Molecular Weight (Monoisotopic): 370.0736 | AlogP: 3.90 | #Rotatable Bonds: 6 |
Polar Surface Area: 111.16 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.21 | CX Basic pKa: ┄ | CX LogP: 3.09 | CX LogD: 3.09 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.40 | Np Likeness Score: -2.28 |
References
1. Karabanovich G, Němeček J, Valášková L, Carazo A, Konečná K, Stolaříková J, Hrabálek A, Pavliš O, Pávek P, Vávrová K, Roh J, Klimešová V.. (2017) S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents., 126 [PMID:27907875] [10.1016/j.ejmech.2016.11.041] |